APOL5
gene geneOn this page
Also known as APOLV
Summary
APOL5 (apolipoprotein L5, HGNC:14869) is a protein-coding gene on chromosome 22q12.3, encoding Apolipoprotein L5 (Q9BWW9). May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles.
This gene is a member of the apolipoprotein L gene family. The encoded protein is found in the cytoplasm, where it may affect the movement of lipids or allow the binding of lipids to organelles.
Source: NCBI Gene 80831 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 81 total
- GTEx eGene: eQTL in 9 tissues, sQTL in 0 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.09 (unconstrained)
- MANE Select transcript:
NM_030642 - Notable: 81 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14869 |
| Approved symbol | APOL5 |
| Name | apolipoprotein L5 |
| Location | 22q12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | APOLV |
| Ensembl gene | ENSG00000128313 |
| Ensembl biotype | protein_coding |
| OMIM | 607255 |
| Entrez | 80831 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
MANE Select: ENST00000249044
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1
ENST00000249044
RefSeq mRNA: 1 — MANE Select: NM_030642
NM_030642
CCDS: CCDS13920
Canonical transcript exons
ENST00000249044 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000880021 | 35726211 | 35727194 |
| ENSE00000880022 | 35728723 | 35728904 |
| ENSE00000911244 | 35717872 | 35717926 |
| ENSE00000936034 | 35729354 | 35729483 |
| ENSE00001275737 | 35720568 | 35720654 |
Expression profiles
Bgee: expression breadth broad, 36 present calls, max score 84.33.
Highest expression (Bgee): male germ line stem cell (sensu Vertebrata) in testis, primordial germ cell in gonad, hindlimb stylopod muscle, skeletal muscle tissue, muscle of leg.
Genetic regulation across tissues (GTEx eQTL / sQTL)
APOL5 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 9 tissues and its splicing (sQTL) in 0 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
9 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Muscle Skeletal | eqtl | 2.0e-64 | -0.55 | 22:35685923:A:C |
| Liver | eqtl | 2.5e-23 | +0.75 | 22:35726883:C:T |
| Adipose Subcutaneous | eqtl | 8.6e-23 | -0.47 | 22:35646939:C:T |
| Nerve Tibial | eqtl | 7.9e-17 | -0.48 | 22:35646939:C:T |
| Breast Mammary Tissue | eqtl | 2.9e-10 | -0.40 | 22:35646939:C:T |
| Adipose Visceral Omentum | eqtl | 3.0e-07 | -0.36 | 22:35646939:C:T |
| Thyroid | eqtl | 3.9e-06 | -0.30 | 22:35646939:C:T |
| Heart Left Ventricle | eqtl | 3.5e-04 | -0.31 | 22:35642029:C:T |
| Artery Coronary | eqtl | 1.6e-03 | -0.37 | 22:35646939:C:T |
Top tissues by expression
99 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.33 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.37 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 59.00 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 57.41 | gold quality |
| muscle of leg | UBERON:0001383 | 53.23 | gold quality |
| gastrocnemius | UBERON:0001388 | 50.61 | gold quality |
| muscle tissue | UBERON:0002385 | 50.05 | gold quality |
| right lobe of liver | UBERON:0001114 | 47.75 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 46.69 | silver quality |
| liver | UBERON:0002107 | 46.66 | gold quality |
| gall bladder | UBERON:0002110 | 44.48 | gold quality |
| apex of heart | UBERON:0002098 | 42.11 | silver quality |
| prefrontal cortex | UBERON:0000451 | 40.60 | gold quality |
| heart left ventricle | UBERON:0002084 | 39.53 | gold quality |
| left testis | UBERON:0004533 | 39.30 | gold quality |
| testis | UBERON:0000473 | 38.78 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 38.61 | silver quality |
| primary visual cortex | UBERON:0002436 | 38.45 | silver quality |
| anterior cingulate cortex | UBERON:0009835 | 37.98 | silver quality |
| thoracic mammary gland | UBERON:0005200 | 37.75 | gold quality |
| frontal cortex | UBERON:0001870 | 37.67 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.36 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| right testis | UBERON:0004534 | 37.14 | gold quality |
| heart | UBERON:0000948 | 37.01 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 36.24 | silver quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| mucosa of stomach | UBERON:0001199 | 36.03 | silver quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 35.91 | silver quality |
| adipose tissue | UBERON:0001013 | 35.90 | silver quality |
| cerebral cortex | UBERON:0000956 | 35.87 | gold quality |
| right coronary artery | UBERON:0001625 | 35.62 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 35.09 | gold quality |
| duodenum | UBERON:0002114 | 32.80 | gold quality |
| left coronary artery | UBERON:0001626 | 31.86 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| lymph node | UBERON:0000029 | 31.47 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 31.31 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 31.10 | gold quality |
| material anatomical entity | UBERON:0000465 | 30.76 | gold quality |
| multicellular organism | UBERON:0000468 | 30.76 | gold quality |
| brain | UBERON:0000955 | 30.31 | gold quality |
| adrenal tissue | UBERON:0018303 | 30.24 | gold quality |
| tonsil | UBERON:0002372 | 30.06 | gold quality |
| vermiform appendix | UBERON:0001154 | 30.02 | silver quality |
| rectum | UBERON:0001052 | 29.92 | gold quality |
| tibial artery | UBERON:0007610 | 29.88 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| popliteal artery | UBERON:0002250 | 29.78 | silver quality |
| cortex of kidney | UBERON:0001225 | 28.93 | silver quality |
| temporal lobe | UBERON:0001871 | 28.77 | silver quality |
| blood | UBERON:0000178 | 28.52 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 28.45 | silver quality |
| amygdala | UBERON:0001876 | 28.39 | silver quality |
| islet of Langerhans | UBERON:0000006 | 28.37 | gold quality |
| endometrium | UBERON:0001295 | 27.73 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 27.38 | gold quality |
| fallopian tube | UBERON:0003889 | 26.91 | gold quality |
| kidney | UBERON:0002113 | 26.68 | gold quality |
| small intestine | UBERON:0002108 | 26.56 | gold quality |
| left uterine tube | UBERON:0001303 | 26.55 | gold quality |
| pancreas | UBERON:0001264 | 26.50 | gold quality |
| leukocyte | CL:0000738 | 26.48 | gold quality |
| monocyte | CL:0000576 | 26.37 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.82 | gold quality |
| ovary | UBERON:0000992 | 25.56 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 25.49 | gold quality |
| right ovary | UBERON:0002118 | 25.06 | gold quality |
| nucleus accumbens | UBERON:0001882 | 24.86 | gold quality |
| lung | UBERON:0002048 | 24.71 | gold quality |
| left ovary | UBERON:0002119 | 24.61 | gold quality |
| body of stomach | UBERON:0001161 | 24.52 | gold quality |
| skin of leg | UBERON:0001511 | 24.49 | gold quality |
| right lung | UBERON:0002167 | 24.49 | gold quality |
| body of pancreas | UBERON:0001150 | 24.27 | gold quality |
| zone of skin | UBERON:0000014 | 24.09 | gold quality |
| vagina | UBERON:0000996 | 23.66 | gold quality |
| prostate gland | UBERON:0002367 | 23.37 | gold quality |
| corpus callosum | UBERON:0002336 | 23.36 | gold quality |
| skin of abdomen | UBERON:0001416 | 23.25 | gold quality |
| adrenal gland | UBERON:0002369 | 23.14 | gold quality |
| transverse colon | UBERON:0001157 | 23.10 | gold quality |
| body of uterus | UBERON:0009853 | 23.05 | gold quality |
| right adrenal gland | UBERON:0001233 | 22.82 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 22.52 | gold quality |
| ectocervix | UBERON:0012249 | 22.22 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 21.93 | gold quality |
| left adrenal gland | UBERON:0001234 | 21.59 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 21.50 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 21.43 | gold quality |
| spleen | UBERON:0002106 | 21.11 | gold quality |
| granulocyte | CL:0000094 | 20.63 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 19.74 | gold quality |
| adenohypophysis | UBERON:0002196 | 19.40 | gold quality |
| right uterine tube | UBERON:0001302 | 16.49 | gold quality |
| metanephros cortex | UBERON:0010533 | 15.43 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.66 |
HPA expression
RNA tissue specificity: Tissue enhanced
18 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Tongue | tissue | 1.9 |
| Skeletal muscle | tissue | 1.3 |
| Cerebral cortex | tissue | 0.4 |
| Hippocampal formation | tissue | 0.3 |
| Testis | tissue | 0.2 |
| Heart muscle | tissue | 0.2 |
| Amygdala | tissue | 0.2 |
| Cerebellum | tissue | 0.2 |
| Pons | tissue | 0.1 |
| Adipose tissue | tissue | 0.1 |
| Basal ganglia | tissue | 0.1 |
| Medulla oblongata | tissue | 0.1 |
| Hypothalamus | tissue | 0.1 |
| Gallbladder | tissue | 0.1 |
| Hippocampus | tissue | 0.1 |
| Postcentral gyrus | tissue | 0.1 |
| Retrosplenial cortex | tissue | 0.1 |
| Occipital cortex | tissue | 0.1 |
Brain sub-regions (HPA Brain Atlas): detected in 68; highest nTPM — Parieto-insular cortex (0.4), Hippocampus, CA3 (0.3), Posterior insular cortex (0.3), Angular gyrus (white matter) (0.2), Anterior insular cortex, ventral (0.2).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting APOL5 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
8 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-12121 | 99.99 | 66.64 | 255 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-361-3P | 99.19 | 66.45 | 1381 |
| HSA-MIR-4317 | 98.49 | 67.09 | 987 |
| HSA-MIR-1912-5P | 97.94 | 67.98 | 832 |
| HSA-MIR-3152-5P | 96.98 | 66.88 | 819 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
Functional genomics
gnomAD constraint: pLI 4.32e-08, LOEUF 1.09, missense Z 0.586 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD)
ENST00000249044 splits into 3 regions with different missense tolerance; 0 are missense-constrained. Missense variants in a constrained region (low observed/expected) are more likely to be pathogenic. gnomAD
| Region (GRCh38) | Missense obs / exp | o/e | Constrained |
|---|---|---|---|
| 22:35,717,872–35,726,712 | 254 / 254.7 | 1.00 | no |
| 22:35,726,713–35,726,825 | 22 / 46.6 | 0.47 | no |
| 22:35,726,826–35,728,895 | 238 / 229.1 | 1.04 | no |
Literature-anchored findings (GeneRIF, showing 1)
- APOL5 has been found only in humans (PMID:11374903)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| caenorhabditis_elegans | WBGENE00017219 | |
| caenorhabditis_elegans | WBGENE00017220 |
Paralogs (6): APOL4 (ENSG00000100336), APOL1 (ENSG00000100342), APOL3 (ENSG00000128284), APOL2 (ENSG00000128335), APOLD1 (ENSG00000178878), APOL6 (ENSG00000221963)
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| RBFOX2 | protein-coding | 23543 |
| APOL3 | protein-coding | 80833 |
| MB | protein-coding | 4151 |
| APOL6 | protein-coding | 80830 |
Protein
Protein identifiers
Apolipoprotein L5 — Q9BWW9 (reviewed: Q9BWW9)
Alternative names: Apolipoprotein L-V
All UniProt accessions (1): Q9BWW9
UniProt curated annotations — full annotation on UniProt →
Function. May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles.
Subcellular location. Cytoplasm.
Tissue specificity. Low level of expression; detected in uterus, testis, skeletal muscle and stomach.
Similarity. Belongs to the apolipoprotein L family.
RefSeq proteins (1): NP_085145* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008405 | ApoL | Family |
Pfam: PF05461
UniProt features (8 total): sequence variant 4, compositionally biased region 2, chain 1, region of interest 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BWW9-F1 | 41.66 | 0.00 |
Human Protein Atlas
Protein class: Predicted intracellular proteins, Plasma proteins, UniProt - Evidence at transcript level
Protein evidence: Evidence at transcript level
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 22 (showing top):
GOBP_LIPOPROTEIN_METABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_LIPID_LOCALIZATION, GOMF_PROTEIN_LIPID_COMPLEX_BINDING, GOMF_LIPID_BINDING, GOMF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_BINDING, GOMF_PROTEIN_CONTAINING_COMPLEX_BINDING, ZNF22_TARGET_GENES, MIR4317, chr22q12, DESCARTES_MAIN_FETAL_SMOOTH_MUSCLE_CELLS, DESCARTES_FETAL_HEART_SMOOTH_MUSCLE_CELLS, NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP, GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN
GO Biological Process (3): lipid metabolic process (GO:0006629), lipid transport (GO:0006869), lipoprotein metabolic process (GO:0042157)
GO Molecular Function (2): high-density lipoprotein particle binding (GO:0008035), lipid binding (GO:0008289)
GO Cellular Component (3): extracellular region (GO:0005576), cytoplasm (GO:0005737), membrane (GO:0016020)
GO top-level categories
8 GO namespaces:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| primary metabolic process | 1 |
| transport | 1 |
| lipid localization | 1 |
| protein metabolic process | 1 |
| lipoprotein particle binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
showing 15 of 290 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| APOL5 | COMT | P21964 | 671 |
| APOL5 | CIMIP2C | A6NJV1 | 496 |
| APOL5 | APOO | Q9BUR5 | 470 |
| APOL5 | HPR | P00739 | 468 |
| APOL5 | APOC4 | P55056 | 401 |
| APOL5 | APOLD1 | Q96LR9 | 391 |
| APOL5 | OR10H5 | Q8NGA6 | 387 |
| APOL5 | APOL1 | O14791 | 363 |
| APOL5 | APOF | Q13790 | 357 |
| APOL5 | APOL4 | Q9BPW4 | 351 |
| APOL5 | APOM | O95445 | 323 |
| APOL5 | NPIPB9 | F8W1W9 | 322 |
| APOL5 | NT5DC4 | Q86YG4 | 309 |
| APOL5 | ZNF441 | Q8N8Z8 | 297 |
| APOL5 | HP | P00737 | 293 |
IntAct
Human interaction partners of APOL5 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
8 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| ABL1 | physical association | 0.400 | 1 |
| CLTCL1 | physical association | 0.400 | 1 |
| CRK | physical association | 0.400 | 1 |
| FYN | physical association | 0.400 | 1 |
| GRB2 | physical association | 0.400 | 1 |
| NCK1 | physical association | 0.400 | 1 |
| PIK3R1 | physical association | 0.400 | 1 |
| SRC | physical association | 0.400 | 1 |
BioGRID (2 interactions; top human partners by supporting records): CLTCL1 (Affinity Capture-MS), CUL3 (Affinity Capture-MS)
Disease & clinical
Genetic variants
Variant evidence for APOL5: 81 ClinVar records (0 pathogenic / likely pathogenic); 3 GWAS associations.
ClinVar
81 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 69 |
| Likely benign | 6 |
| Benign | 2 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 14 predictions of 364):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 22:35717927–35717928 | donor_loss | 0.9800 | 5 |
| 22:35720461 | acceptor_gain | 0.9700 | |
| 22:35726397 | acceptor_gain | 0.9500 | |
| 22:35726395 | acceptor_gain | 0.9100 | |
| 22:35726307 | acceptor_gain | 0.8700 | |
| 22:35728754 | acceptor_gain | 0.8000 | |
| 22:35720469 | acceptor_gain | 0.7900 | |
| 22:35720473 | acceptor_gain | 0.7900 | |
| 22:35727129 | donor_gain | 0.7900 | |
| 22:35729346 | acceptor_gain | 0.7700 |
AlphaMissense
112 missense substitutions predicted likely pathogenic (of 2,813 scored), across 62 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| F106 | 5 | 0.786 | 0.877 |
| M151 | 5 | 0.670 | 0.676 |
| F255 | 4 | 0.800 | 0.869 |
| G173 | 4 | 0.612 | 0.691 |
| G175 | 4 | 0.605 | 0.645 |
| S166 | 3 | 0.846 | 0.846 |
| F102 | 3 | 0.824 | 0.824 |
| F280 | 3 | 0.815 | 0.815 |
| F270 | 3 | 0.802 | 0.802 |
| F262 | 3 | 0.796 | 0.796 |
| F111 | 3 | 0.730 | 0.730 |
| F301 | 3 | 0.721 | 0.721 |
| F215 | 3 | 0.706 | 0.706 |
| S142 | 3 | 0.659 | 0.659 |
| F79 | 3 | 0.581 | 0.581 |
| R330 | 2 | 0.733 | 0.733 |
| A124 | 2 | 0.722 | 0.769 |
| K110 | 2 | 0.712 | 0.712 |
| A141 | 2 | 0.710 | 0.720 |
| R199 | 2 | 0.695 | 0.695 |
HPA cancer prognostics
RNA cancer specificity: Not detected
Disease associations
OMIM: gene MIM:607255 | disease phenotypes:
GWAS associations
3 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST005958_5 | Waist-to-hip ratio adjusted for BMI (age >50) | 1e-6 |
| GCST002301_5 | Body mass index | 3e-6 |
| GCST005962_58 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 6e-6 |
EFO canonical traits (from GWAS)
4 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| 3,4,5,3’,4’-pentachlorobiphenyl | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Rotenone | increases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.